US House Drug Pricing Bill Amended To Target Launch Prices, Set For Swift Advance

 
• By Cathy Kelly

House Speaker Pelosi’s amended HR 3 expands scope of targeted drugs, adds manufacturer transparency requirements ahead of dual markups and a hearing on 17 October.

Washington DC / USA - July 26 2019: House Speaker Nancy Pelosi holds a press conference - Image
Pelosi Drug Pricing Bill May Get Floor Vote Later This Month

More from Pricing Debate

More from Market Access